Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Other: control groupBehavioral: exercise group
- Registration Number
- NCT04639349
- Lead Sponsor
- Cairo University
- Brief Summary
exercise activity during the COVID pandemic is appreciated to be conducted in home especially for chronic chest diseases as chronic obstructive pulmonary disease (COPD) to reduce the chance of viral contamination during the COVID-19 pandemic.
- Detailed Description
40 COPD men will be divided to exercise group (20 patients) and control group (20 patients):
the exercise group will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.
The control group will not be trained
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 40
- stable COPD patients
- patients who will have a training device as bicycle or treadmill in home
- diabetic patients
- renal patients.
- liver diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description control group control group The control group will not be trained Exercised group exercise group the exercise group (20 patients) will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.
- Primary Outcome Measures
Name Time Method hospital anxiety and depression scale It will be measured after eight weeks of training this a questionnaire that will assess anxiety and depression in COPD patients
cortisol It will be measured after eight weeks of training it will be measured in plasma
- Secondary Outcome Measures
Name Time Method Interleukin-8 It will be measured after eight weeks of training It is an inflammatory marker in plasma
pulmonary function test It will be measured after eight weeks of training it will be a measurement for lung volume and capacities
body mass index It will be measured after eight weeks of training it will measure body mass changes
six minute walking test It will be measured after eight weeks of training it assess functional capacity
St. George's respiratory questionnaire It will be measured after eight weeks of training It assess the effect of COPD on general quality of life
Trial Locations
- Locations (1)
Faculty of Physical Therapy Cairo University
🇪🇬Giza, Dokki, Egypt